The purpose of this protocol is to provide a comprehensive, step-by-step approach for evaluating autonomic function at the bedside, focusing on the circulatory, sudomotor, urinary, and bowel systems. Autonomic dysfunction is a key feature of PD and MSA, which provides crucial diagnostic and prognostic information. In patients with PD and MSA, autonomic dysfunction affects daily life and progresses over time. Impaired communication can make it difficult for patients to report symptoms. Therefore, mastering noninvasive bedside assessment protocols for autonomic dysfunction is necessary. However, bedside assessments are often performed inconsistently in clinical practice. Several studies have reported new bedside methods for assessing and interpreting autonomic dysfunction in patients with PD and MSA. However, it is difficult for clinicians to grasp all of these at once and to judge their priorities. This manuscript therefore reviews and summarizes existing reports.
The primary benefits of bedside protocols in the clinical management of patients with PD and MSA are accessibility and sustainability. Various methods exist for the detailed assessment of autonomic function; however, they often face limitations in terms of institutional accessibility, invasiveness, and time requirements. For example, the head-up tilt test, which is valuable for assessing blood pressure (BP) variability, requires the use of a tilt table1. For sudomotor function, the thermoregulatory sweat test requires a special chamber, while the quantitative sudomotor axon reflex test requires a multi-compartmental sweat capsule2. Although these methods provide highly reliable results, their limited availability renders long-term monitoring impractical. Furthermore, although urodynamic testing is useful for evaluating lower urinary tract dysfunction, it is invasive because it requires catheterization and requires high clinical expertise for equipment operation and calibration3. Given these constraints, routinely performing these tests for the clinical management of patients with PD or MSA remains challenging. Therefore, the development of practical bedside assessment protocols is essential.
Although various methods for the bedside assessment of autonomic dysfunction have been reported individually in the literature, even existing comprehensive literature and textbooks often merely list these methods exhaustively. Consequently, they lack a systematic framework that guides clinicians in prioritizing tests, leaving many detailed procedures unclear4,5,6. Furthermore, existing research protocols generally assume that patients can fully complete the examinations. Therefore, they lack comprehensive guidelines for addressing clinical challenges, such as cases where tests cannot be completed7,8, equipment is unavailable, or troubleshooting is required. This protocol addresses this gap by integrating circulatory, sudomotor, urinary, and bowel assessments into a step-by-step protocol and tiered workflow (Figure 1), comprising core bedside screening (Core), optional bedside instrumental assessment (Optional), and advanced or referral-level testing (Advanced) examinations specifically applicable to patients with PD and MSA. It further provides disease-specific interpretations, contraindications, common sources of errors, troubleshooting, and alternative approaches when the procedure cannot be completed. The protocol is based on previously established methods and current diagnostic criteria; as such, its contribution is not the introduction of a new diagnostic test, but the development of a practical and reproducible framework for bedside autonomic assessment.
‘Core’ screening refers to essential screening tasks that can be performed in any setting. Such techniques require no specialized equipment other than the tools available in all medical institutions, such as sphygmomanometers, which are cost-effective and technically accessible. The 'Optional' assessment involves the use of specialized tools; while not strictly mandatory, these tests are highly recommended for the diagnosis and practice of patients with PD and MSA, and can be conducted with minimal training. Conversely, 'Advanced' testing encompasses tests which are beneficial for the management of MSA and PD, but not strictly essential. Such tests should require specialized equipment and a significant training period to achieve proficiency. Although autonomic dysfunction is associated with various neurodegenerative diseases, onset time, clinical characteristics, and diagnostic criteria vary across individual diseases.
In this paper, the protocols and interpretations focus on autonomic dysfunction associated with PD or MSA; therefore, the clinical features and interpretations do not apply to all neurodegenerative diseases. In this manuscript, the section titled “Bedside Assessment Protocol” provides the protocols and methods for interpretation. The section titled "Representative Results" outlines important considerations and how to apply the findings in clinical practice in PD and MSA.